AUA Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-574
Closed -$75.4K 196
2022
Q4
$75.4K Sell
574
-15
-3% -$1.94K 0.05% 123
2022
Q3
$69K Sell
589
-131
-18% -$16.3K 0.05% 121
2022
Q2
$85K Hold
720
0.05% 121
2022
Q1
$94K Hold
720
0.05% 121
2021
Q4
$110K Hold
720
0.06% 109
2021
Q3
$116K Hold
720
0.07% 103
2021
Q2
$118K Hold
720
0.07% 104
2021
Q1
$108K Hold
720
0.07% 107
2020
Q4
$109K Hold
720
0.08% 102
2020
Q3
$97K Hold
720
0.08% 99
2020
Q2
$98K Hold
720
0.1% 90
2020
Q1
$78K Hold
720
0.07% 99
2019
Q4
$87K Sell
720
-480
-40% -$53.6K 0.07% 101
2019
Q3
$119K Hold
1,200
0.1% 96
2019
Q2
$131K Hold
1,200
0.11% 91
2019
Q1
$134K Hold
1,200
0.11% 92
2018
Q4
$116K Hold
1,200
0.11% 93
2018
Q3
$146K Hold
1,200
0.12% 90
2018
Q2
$132K Hold
1,200
0.12% 88
2018
Q1
$128K Hold
1,200
0.11% 93
2017
Q4
$128K Hold
1,200
0.12% 96
2017
Q3
$133K Hold
1,200
0.12% 92
2017
Q2
$124K Buy
1,200
+345
+40% +$34K 0.11% 97
2017
Q1
$84K Sell
855
-1,200
-58% -$115K 0.08% 74
2016
Q4
$182K Buy
+2,055
New +$187K 0.17% 70

Other funds holding IBB

AUA Capital Management's IBB Position: Q1 2023 in Review

AUA Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 574 shares — an estimated $75.4K sold.

AUA Capital Management first reported a position in IBB in Q4 2016 and held it in 25 quarters. The position peaked at $182K in Q4 2016. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • AUA Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • AUA Capital Management sold 574 iShares Biotechnology ETF shares in Q1 2023, an estimated $75.4K.
  • AUA Capital Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 25 quarters.
  • AUA Capital Management's iShares Biotechnology ETF position peaked at $182K in Q4 2016.
  • 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on AUA Capital Management's 13F filing for Q1 2023, filed 20 Apr 2023.